The newly constituted African Medicines Agency (AMA) will be key in assisting the African Union (AU) to achieve its aim of producing 60% of vaccines on its own soil by 2040. This emerged at a two-day meeting of the Partnership for Africa Vaccine Manufacturing (PAVM) hosted by Rwanda this week. The PAVM was set up […] Continue reading ->
The African Union has made steady progress to manufacture vaccines on the continent, but this is a complicated, expensive endeavour that required long-term commitment, Big Pharma companies warned. Welcoming delegates to the Partnership for African Vaccine Manufacturing (PAVM) reportback six months after it was set up, Rwandan President Paul Kagame said building pharmaceutical manufacturing […] Continue reading ->
A special session of the World Health Assembly is under way this week with just one item under consideration – Pandemic Treaty. Will a pandemic treaty be able to help address deficiencies in global solidarity, and improve access to essential lifesaving medicines, vaccines, and tools? The short answer is no. Not without the political will […] Continue reading ->
In a first face-to-face meeting in Geneva since the start of the COVID-19 pandemic, the World Health Organization’s 194 member states appeared set to adopt a landmark decision to negotiate a new treaty or framework convention governing pandemic response, dubbed “Our World Together”, and with over 100 countries now declaring co-sponsorship. But from the start […] Continue reading ->
As pandemic treaty negotiations kick off again at the World Health Organization (WHO) in Geneva this week, countries face a stark choice. Will they decide to move ahead on a new system that vests an independent entity with greater powers to monitor their own national alert and responses – in the name of faster pandemic […] Continue reading ->
Human rights lawyers have threatened legal action against the governments of Canada, Germany, Norway and the United Kingdom if they fail to support a waiver of the Trade-Related Intellectual Property Rights (TRIPs) Agreement in relation to COVID-19 healthcare products. The waiver will be discussed at the 12th Ministerial Conference of the World Trade Organization (WTO) […] Continue reading ->
CAPE TOWN – A new COVID-19 variant with a “very unusual constellation of mutations” – currently referred to as B.1.1.529 – has been identified in southern Africa, South Africa’s Health Ministry announced on Thursday. On Friday, WHO dubbed the variant “Omicron”, adding it to its list of variants of concern – even as the European […] Continue reading ->
Russia’s Sputnik V COVID-19 vaccine demonstrates an 80% efficacy six to eight months after the second dose – a higher efficacy than officially published mRNA vaccines, announced the Russian Direct Investment Fund (RDIF) in a press briefing on Wednesday. The efficacy data is based on “real-world data from the Ministry of Health of the Republic […] Continue reading ->
The first non-exclusive license for a COVID-19 health tool – a serological antibody test that checks for the presence of anti-SARS-CoV-2 antibodies – has been finalised by the World Health Organization’s (WHO) COVID-19 Technology Access Pool (C-TAP) and the Medicines Patent Pool (MPP). The license, announced on Tuesday in partnership with the Spanish National Research […] Continue reading ->
The United States Food and Drug Administration (US FDA) on Friday gave its greenlight to the mass rollout of both Pfizer and Moderna COVID booster shots to all adults over the age of 18, from six months after a person’s second vaccine dose. J&J vaccine boosters would be authorized after just two months of the […] Continue reading ->